Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 127Breast 84Lymphoid 37Plasma cell 33Sarcoma 19Genitourinary 11Other hematologic neoplasm 10Gastrointestinal 9Other solid neoplasm 8Tumor-Agnostic 7Thoracic 7Dermatologic 5CNS 4Head & Neck 2Other neoplasm 1NET 1Myeloid 1Endocrine 1Classical hematology 1

Conditions

Unrecognized Condition 1

Interventions

Cyclophosphamide 13Peripheral Blood Stem Cell Transplantation 9Biopsy 9fludarabine phosphate 8Busulfan 8Whole-Body Irradiation 7Surveys and Questionnaires 6Mycophenolic Acid 6Educational Status 6Early Intervention, Educational 6Carboplatin 6fludarabine 5Tacrolimus 5Paclitaxel 5Methotrexate 5Methods 5Melphalan 5Epoetin Alfa 5Decitabine 5Cyclosporine 5Colposcopy 5Cisplatin 5Celecoxib 5Antilymphocyte Serum 5Aminolevulinic Acid 5Sulindac 4Selenium 4Radiotherapy 4Patient Reported Outcome Measures 4Magnetic Resonance Spectroscopy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × liposomal doxorubicin × Other neoplasm × Clear all
NCT04213612 2019-12-30

DCV in the Treatment of Recurrence and Refractory Childhood Solid Tumors

Sun Yat-sen University

Phase 1 Unknown
21 enrolled
Other neoplasm

Unrecognized Condition

Data powered by HemOnc (CC BY 4.0) Colophon âš¡